REPLIGEN CORP 8-K

What Happened
Repligen Corporation announced the results of its 2026 Annual Meeting of Stockholders held May 14, 2026 (record date March 16, 2026). Of 56,399,274 shares outstanding, 54,022,359 were represented, constituting a quorum. Stockholders elected all nine director nominees named in the proxy, ratified Ernst & Young LLP as the independent registered public accounting firm for 2026, and approved, on a non-binding advisory basis, the compensation of the named executive officers.

Key Details

• Quorum: 54,022,359 shares represented of 56,399,274 outstanding (record date March 16, 2026).
• Directors elected (final votes shown): Olivier Loeillot (51,750,665 for), Martin Madaus (51,091,036 for), Karen A. Dawes (42,726,647 for), Nicolas M. Barthelemy (51,526,602 for), Carrie Eglinton Manner (41,987,697 for), Konstantin Konstantinov (51,137,462 for), Rohin Mhatre (51,649,920 for), Glenn P. Muir (38,592,456 for), Margaret A. Pax (51,011,846 for). Broker non-votes on director elections: 2,124,113.
• Auditor ratified: Ernst & Young LLP — 53,092,462 for, 900,084 against, 29,813 abstentions.
• Advisory (non-binding) vote on executive compensation: 50,333,558 for, 1,513,515 against, 51,173 abstain; broker non-votes: 2,124,113.

Why It Matters
The filing confirms governance outcomes that affect oversight and stewardship: the board slate was approved, the independent auditor for fiscal 2026 was ratified, and shareholders expressed a clear majority support for executive pay (non-binding). Investors can view these results as confirmation of continuity in board composition and audit oversight; the advisory pay vote may inform management and the board's future compensation decisions. The detailed vote counts (including significant opposition on some director elections) provide transparency on shareholder sentiment.